New Bronchoscopy Techniques are Helping in the Early Detection of Lung Cancer

Bronchoscopy Procedure

Augmented Fluoroscopy Shows Promise in Lung Cancer Detection

A rise in the number of lung cancer cases across the globe is expected to boost demand for single-use bronchoscopes.

Doctors at a California hospital are using innovative imaging technology to help improve lung cancer diagnosis by better sample collection from areas of the lungs that are difficult to reach.

Called augmented fluoroscopy, the procedure being done at Scripps Green Hospital in La Jolla, Calif., combines imaging studies, augmented reality and artificial intelligence to collect and integrate patient information and give doctors a better view of the airways and location of the pulmonary lesion throughout a bronchoscopy.

The goal of the new procedures is to provide early and accurate detection of suspicious lung nodules since patients diagnosed early have a far greater chance of survival.

The American Cancer Society identifies lung cancer as the leading cause of cancer death in the United States.

For the most common form of lung cancer (non-small cell), the five-year relative survival rate for patients diagnosed at an early localized stage is 63 percent, compared with a 7 percent relative survival rate for patients diagnosed at a later stage.

Bronchoscopy is typically used in the diagnosis, endoscopic study and treatment of the tracheobronchial tree and airways. Bronchoscopes help in the detection of tumors, COPD, lung cancer, bronchitis and other lung infections.

Fluoroscopy enables a continuous X-ray beam to be passed through an internal organ and transmitted to a monitor so the organ and its motion can be seen in detail.

In these new augmented fluoroscopy procedures, software connects to existing fluoroscopy equipment that doctors use during the bronchoscopy to create moving images of the airways and location of the nodule in a CT-like image that doctors can monitor in real time during the procedure.

In April, six doctors published a multicenter study in the Journal of Bronchology & Interventional Pulmonology that assessed the localization success rate and diagnostic yield of bronchoscopes using this navigation platform.

That study included 55 patients and found the nodule localization success rate to be 93 percent during bronchoscopy.

A rise in the number of lung cancer cases across the globe is expected to boost demand for single-use bronchoscopes, according to marketing data from BioSpace. Specifically, in the U.S., aging baby boomers contribute to the rise in people living with such chronic respiratory health issues as COPD. Single-use bronchoscopes require no reprocessing or repairs and eliminate the risk of cross-contamination.

More Pulmonology Articles
Respiratory Care Week 2022: The Future of Respiratory Care
Respiratory Care Week
The American Association for Respiratory Care (AARC) has devised a strategic plan to nurture workforce recovery, promote diversity, equity and inclusion, and to reimagine its brand. We talk to its executive director about these initiatives.
APIC: It’s Time to Reevaluate Infection Preventionists’ Workload
Preventing Infection
Given the unrelenting waves of the novel coronavirus, it is vital to make sure IPs can focus on patient safety and infection monitoring rather than paperwork, the Association for Professionals in Infection Control and Epidemiology says.
More From Single-Use Endoscopy
Study: Visual Inspection Found Damage and Debris in All Reprocessed Scopes Tested

Prevention Challenges

Borescopes and additional magnification revealed damage and residue or debris on all the fully reprocessed endoscopes examined in a recent study.

What is the ‘Holiday Effect’ on ERCPs?

Gastrointestinal Endoscopy Procedure

Researchers have found certain post-ERCP complications to be more frequent in December. But why?

Medicare penalties for high readmissions are lower than they have been, but still affect nearly 2,300 U.S. hospitals.

Value-Based Care

Lowering readmission rates remains a national priority for payers, providers and policymakers seeking to improve healthcare while reducing costs.